MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$93,928,566
Short-term investments
$6,480,860
Prepaid expenses and
other current assets
$828,329
Total current assets
$101,237,755
Property and equipment,
net
$2,521,621
Right-of-use asset, net
$966,917
Deferred offering costs
$93,630
Other assets
$20,418
Total assets
$104,840,341
Total liabilities and
stockholders equity
$104,840,341
Total stockholders
equity
$93,796,170
Total liabilities
$11,044,171
Accumulated deficit
-$104,463,284
Treasury stock at cost,
72,363 shares as of...
$99,963
Additional paid-in capital
$198,293,956
Total current
liabilities
$10,110,546
Operating lease
liabilities - long term
$933,625
Accumulated other
comprehensive income
$60,160
Common stock, 0.0001
par value...
$5,301
Accounts payable and
accrued expenses
$9,971,207
Operating lease
liabilities - current
$139,339
Back
Back
Balance Sheet
source: myfinsight.com
Immix Biopharma, Inc. (IMMX)
Immix Biopharma, Inc. (IMMX)